Psoriasis is a chronic autoimmune skin disease that affects millions of people worldwide. Despite the availability of conventional treatments, many patients seek alternative or complementary therapies for managing their symptoms. Phytocompounds, which are naturally occurring compounds derived from plants, have shown promising potential in the management of psoriasis. This review provides a comprehensive overview of the different classes of phytocompounds that have been studied for their potential in psoriasis management, including HaCaT cell inhibitors, anti-proliferatives, cytokine inhibitors, cyclooxygenase-lipoxygenase inhibitors, pathway targets, interleukin inhibitors, and JAKSTAT pathway inhibitors. Studies have demonstrated the ability of these phytocompounds to modulate key pathogenic pathways involved in psoriasis, such as inflammation, cell proliferation, and cytokine production. While further research is needed to fully elucidate the mechanisms of action and efficacy of phytocompounds in psoriasis management, these findings suggest that they have the potential to serve as alternative or complementary therapies for patients with psoriasis